Evolus

(NASDAQ) EOLS

Current Price$6.40

Market Cap$420.81M

Since IPO (2018)-45%

5 Year-30%

1 Year-46%

1 Month+57%

Evolus Financials at a Glance

Market Cap

$420.81M

Revenue (TTM)

$301.79M

Net Income (TTM)

$43.42M

EPS (TTM)

$-0.67

P/E Ratio

-9.53

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$6.40

Volume

938,533

Open

$6.30

Price

$6.40

Volume

938,533

Open

$6.30

Previous Close

$6.39

Daily Range

$6.27 - $6.58

52-Week Range

$3.86 - $10.62

Dividend

$0.00

Beta (Volatility)

1.12 (Average)

Price

$6.40

Volume

938,533

Open

$6.30

Previous Close

$6.39

Daily Range

$6.27 - $6.58

52-Week Range

$3.86 - $10.62

EOLS News

Page 1

EOLS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Evolus

Industry

Pharmaceuticals

Sector

Health Care

Employees

334

CEO

David Moatazedi, MBA

Website

www.evolus.com

Headquarters

Newport Beach, CA 92660, US

EOLS Financials

Key Financial Metrics (TTM)

Gross Margin

65%

Operating Margin

-10%

Net Income Margin

-14%

Return on Equity

-18730%

Return on Capital

-19%

Return on Assets

-20%

Earnings Yield

-10.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$420.81M

Shares Outstanding

65.85M

Volume

938.53K

Avg. Volume

1.12M

Financials (TTM)

Gross Profit

$192.76M

Operating Income

$37.60M

EBITDA

$28.86M

Operating Cash Flow

$42.27M

Capital Expenditure

$3.44M

Free Cash Flow

$45.71M

Cash & ST Invst.

$53.83M

Total Debt

$155.00M

Evolus Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$73.14M

+6.7%

Gross Profit

$47.36M

+1.5%

Gross Margin

64.75%

N/A

Market Cap

$420.81M

N/A

Market Cap/Employee

$1.13M

N/A

Employees

372

N/A

Net Income

$10.67M

+43.5%

EBITDA

$4.17M

+66.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$115.11M

-84.7%

Accounts Receivable

$52.22M

+10.0%

Inventory

$24.80M

+147.3%

Long Term Debt

$162.35M

+26.6%

Short Term Debt

$2.55M

+29.7%

Return on Assets

-19.68%

N/A

Return on Invested Capital

-18.90%

N/A

Free Cash Flow

$10.37M

+40.7%

Operating Cash Flow

$9.95M

+36.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

AUTLAutolus Therapeutics plc

AUTLAutolus Therapeutics plc$1.61-5.29%

TOIThe Oncology Institute, Inc.

TOIThe Oncology Institute, Inc.$4.07+7.11%

KIDSOrthoPediatrics Corp.

KIDSOrthoPediatrics Corp.$17.57+2.63%

KMDAKamada Ltd.

KMDAKamada Ltd.$8.26-0.24%

NGNENeurogene Inc.

NGNENeurogene Inc.$31.26-3.31%

SLDBSolid Biosciences Inc.

SLDBSolid Biosciences Inc.$7.07-1.81%

QSIQuantum-Si incorporated

QSIQuantum-Si incorporated$0.98-4.80%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NVDANvidia

NVDANvidia$211.56+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$33.55-0.03%

AAPLApple

AAPLApple$287.40-0.00%

PLTRPalantir Technologies

PLTRPalantir Technologies$137.08+0.02%

MUMicron Technology

MUMicron Technology$646.52-0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$14.47+0.07%

AMDAdvanced Micro Devices

AMDAdvanced Micro Devices$408.54-0.03%

Questions About EOLS

What is the current price of Evolus?

Evolus is trading at $6.39 per share.

What is the 52-week range for Evolus?

Over the past 52 weeks, Evolus has traded between $3.86 and $10.62.

How much debt does Evolus have?

As of the most recent reporting period, Evolus reported total debt of $164.90M.

How much cash does Evolus have on hand?

Evolus reported $49.79M in cash and cash equivalents in its most recent financial results.

What is Evolus’s dividend yield?

Evolus does not currently have a dividend yield.

Evolus

Evolus Financials at a Glance

EOLS News

Why Evolus Stock Soared Today

Evolus (EOLS) Q2 Revenue Rises 4%

Why Shares of Evolus Are Jumping Thursday

Why Evolus Shares Jumped This Week

Can Evolus Disrupt the Botox Market?

Why Evolus Stock Dived by Almost 19% Today

Here's Why Evolus Stock Tumbled 17.4% Today

Why Penn Virginia, Evolus, and Cousins Properties Slumped Today

EOLS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Evolus

EOLS Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Evolus Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About EOLS

What is the current price of Evolus?

What is the 52-week range for Evolus?

How much debt does Evolus have?

How much cash does Evolus have on hand?

What is Evolus’s dividend yield?

Premium Investing Services